糖尿病胰岛素有效治疗该补充和替代.pptVIP

* * ANA 038 Comparison of the efficacy and safety of NovoMix? 30 and BHI 30 in a twice-daily meal-related regimen, in a mixed population of patients with type 1 and type 2 diabetes. In this 12-week, randomised, open labelled, parallel-group comparison, 294 adult male and female subjects who had been using insulin in a twice-daily regimen were randomised to receive NovoMix? 30, injected within 10 minutes before breakfast and dinner (n = 143), or BHI 30 injected approximately 30 minutes prior to breakfast and dinner (n = 151). Of these, 140 patients were exposed to NovoMix 30, and 151 were ex